Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.67
+0.32 (3.42%)
Apr 2, 2026, 4:00 PM EDT - Market closed

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
30350179424131488
Market Cap Growth
-56.86%-36.98%3156.48%-81.33%-73.20%-
Enterprise Value
11.66208.64586.2496.28-135.81116.36
Last Close Price
9.6716.0028.8712.4015.7158.83
PE Ratio
--5.61-12.34-0.35--3.43
PS Ratio
15.8826.23----
PB Ratio
1.071.763.89-0.280.441.27
P/TBV Ratio
0.981.623.01-0.590.220.63
P/FCF Ratio
--7.15-13.27-0.40-1.38-8.32
P/OCF Ratio
--7.24-13.38-0.40-1.49-9.22
EV/Sales Ratio
0.6110.93----
EV/EBITDA Ratio
--2.30-10.01-1.331.31-1.95
EV/EBIT Ratio
--2.29-10.00-1.331.29-1.93
EV/FCF Ratio
--2.98-9.79-1.591.44-1.99
Debt / Equity Ratio
0.000.000.000.000.010.02
Debt / EBITDA Ratio
0.000.00-0.010.00-0.06-0.19
Debt / FCF Ratio
0.000.00-0.010.00-0.06-0.19
Net Debt / Equity Ratio
-1.03-1.03-1.020.76-0.89-0.95
Net Debt / EBITDA Ratio
3.213.213.560.912.546.13
Net Debt / FCF Ratio
4.174.173.481.092.786.24
Asset Turnover
0.070.070000
Inventory Turnover
0.280.28----
Quick Ratio
13.8113.8120.093.5520.5631.04
Current Ratio
14.2314.2320.363.6321.1131.44
Return on Equity (ROE)
-33.63%-33.63%-39.07%-40.33%-29.71%-37.81%
Return on Assets (ROA)
-35.19%-35.19%-41.03%-36.83%-29.19%-28.47%
Return on Invested Capital (ROIC)
1555.53%1555.53%648.93%-469.99%-335.23%-666.19%
Return on Capital Employed (ROCE)
-37.23%-37.23%-45.65%-40.16%-30.24%-31.78%
Earnings Yield
-27.09%-17.81%-8.11%-287.98%0.00%-29.15%
FCF Yield
-23.09%-13.98%-7.53%-247.62%-72.38%-12.02%
Buyback Yield / Dilution
-35.39%-35.39%-415.11%0.00%0.00%-1166.12%
Total Shareholder Return
-35.39%-35.39%-415.11%0.00%0.00%-1166.12%
Updated Mar 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q